Learn more

MSN LABORATORIES PRIVATE LTD R&D CENTER

Overview
  • Total Patents
    41
  • GoodIP Patent Rank
    36,835
  • Filing trend
    ⇧ 100.0%
About

MSN LABORATORIES PRIVATE LTD R&D CENTER has a total of 41 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and macromolecular chemistry and polymers are SUZHOU XINEN MEDICINE TECH CO LTD, LAURUS LABS PRIVATE LTD and LAURUS LABS LTD.

Patent filings in countries

World map showing MSN LABORATORIES PRIVATE LTD R&D CENTERs patent filings in countries

Patent filings per year

Chart showing MSN LABORATORIES PRIVATE LTD R&D CENTERs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Sajja Eswaraiah 31
#2 Srinivasan Thirumalai Rajan 31
#3 Sagyam Rajeshwar Reddy 17
#4 Rangineni Srinivasulu 14
#5 Ghojala Venkat Reddy 11
#6 Thirumalai Rajan Srinivasan 10
#7 Eswaraiah Sajja 10
#8 Gogulapati Venkata Panakala Rao 9
#9 Rajeshwar Reddy Sagyam 7
#10 Bekkam Markandeya 5

Latest patents

Publication Filing date Title
WO2021079380A1 Improved process for the preparation of (2s)-n-{(1s)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)-amino]-2-oxoethyl}-1-(4-cyanopyridin-2-yl)-n-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide
WO2021001858A1 Improved process for the preparation of 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid or its pharmaceutically acceptable salts and polymorphs thereof
WO2020261301A1 IMPROVED PROCESS FOR THE PREPARATON OF PURE (1'R,6R,6aR,7R,13S,14S,16R)-5-(ACETYLOXY)-3',4',6,6a,7,13,14,16-OCTAHYDRO-6',8,14-TRIHYDROXY-7',9-DIMETHOXY-4,10,23-TRIMETHYLSPIRO[6,16-(EPITHIOPROPANOXYMETH ANO)-7,13-IMINO-12H-1,3-DIOXOLO[7,8]ISOQUINO[3,2-b][3]BENZAZOCINE-20,1'(2'H)-ISOQUINOLIN]-19-ONE POLYMORPH THERE OF
WO2020225831A1 Improved process for the preparation of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl)pyrrolidin-2-yl] imidazo[1,5-a]pyrazin-1-yl)}-n-(pyridine-2-yl)benzamide
WO2020222256A1 Polymorphs of 7-cyclopentyl-n,n-dimethyl-2-{[5-(piperazin-1-yl) pyridin-2-yl]-amino}-7h-pyrrolo[2,3-d]pyrimidine-6-carboxamide and its pharmaceutically acceptable salts and process for the preparation thereof
WO2020141562A1 Novel crystalline forms and process for the preparation of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl)}-n-(pyridine-2-yl)benzamide
WO2020070760A1 An improved process for the preparation of 1,2,3-propanetriyl tris(4-phenylbutanoate)
WO2020049599A1 Process for the preparation of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1- yl]methyl}piperazin-1-yl)-n-({3-nitro-4-[(tetrahydro-2h-pyran-4-ylmethyl)amino] phenyl}sulfonyl)-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide)
WO2020031201A1 Improved process for the preparation of 6-aminohexanoic acid
WO2020026273A1 Solid forms of ertugliflozin free base and solid dispersions comprising ertugliflozin l-pyroglutamic acid.
WO2019211868A1 Improved process for the preparation of 9-ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl) piperidin-1-yl]-11-oxo-6,11-dihydro-5h-benzo[b]carbazole-3-carbonitrile hydrochloride
WO2019193607A1 An improved process for the preparation of pregabalin
WO2019193608A1 Improved process for the preparation of iron (iii) carboxymaltose
WO2019167085A1 Process for the preparation of (s)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino propanamide methanesulfonate
WO2019145977A1 PROCESS FOR THE PREPARATION OF 3α,7α-DIHYDROXY6α-ETHYL-5β-CHOLAN-24-OIC ACID
WO2019111283A1 Novel polymorphs of 4-[3-chloro-4-(n'-cyclopropyl ureido)phenoxy]-7-methoxyquinoline-6-carboxamide, its salts and process for the preparation thereof
US2020306225A1 Stable n-((1r,2r)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl) octanamide (2r,3r)-2,3-dihydroxysuccinate premix and process for preparation thereof
WO2019058387A1 An improved process for the preparation of (5α,6α)-17-allyl-6-(2,5,8,11,14,17,20- heptaoxadocosan-22-yloxy)-4,5-epoxymorphinan-3,14-diol and its pharmaceutically acceptable salts
WO2019049174A1 Solid state forms of 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4-(1h,3h)-dione hydrochloride and their processes for the preparation thereof
WO2019043724A1 Processes for the preparation of (s)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl) propanoic acid and polymorphs thereof